<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23952" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Krebs Cycle</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alabduladhem</surname>
            <given-names>Tamim O.</given-names>
          </name>
          <aff>Imam Abdulrahman Bin Faisal University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bordoni</surname>
            <given-names>Bruno</given-names>
          </name>
          <aff>Foundation Don Carlo Gnocchi IRCCS</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tamim Alabduladhem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bruno Bordoni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23952.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The tricarboxylic acid (TCA) cycle, also known as the Krebs or citric acid cycle, is an important cell's metabolic hub (see <bold>Figure</bold>. Krebs Cycle). It comprises&#x000a0;8 enzymes within the mitochondrial matrix except the outlier succinate dehydrogenase, which is related to the respiratory chain on the inner mitochondrial membrane. The cycle is a gateway for aerobic metabolism for molecules that can convert to an acetyl group or dicarboxylic acid. Regulation of the TCA cycle occurs at&#x000a0;3 distinct points, including the following enzymes: citrate synthase, isocitrate dehydrogenase, and alpha-ketoglutarate dehydrogenase. The cycle also plays a role in replenishing precursors for the storage form of fuels such as amino acids and cholesterol.<xref ref-type="bibr" rid="article-23952.r1">[1]</xref></p>
      </sec>
      <sec id="article-23952.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>The Krebs cycle does not require oxygen alone; this element is necessary for the last stage of aerobic cellular respiration, oxidative phosphorylation. Organic molecules endowed with energy (carbohydrates, lipids, proteins) are split in previous reactions. Before entering the Krebs cycle, they transform into acetyl-CoA, a molecule formed by an acetyl group (CH3CO-) and an acyl transporter called coenzyme A.</p>
        <p>However, the preferred source of acetyl-CoA remains glycolysis. The acetyl group is then oxidized, and the energy obtained synthesizes ATP in cooperation with oxidative phosphorylation. In eukaryotes, the Krebs cycle reactions take place in the mitochondrial matrix, a dense solution that surrounds the mitochondria crests: in addition to water, the matrix contains all the enzymes necessary for the biochemical reactions of the cycle, coenzymes and phosphates.The availability of the NAD+ and FAD substrates controls and regulates the Krebs cycle, while high concentrations of NADH inhibit it.</p>
      </sec>
      <sec id="article-23952.s3" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>Glucose metabolism takes place in the cytosol without the need for oxygen through a process called glycolysis. It yields a small amount of ATP, and the 3-carbon compound pyruvate. After the transportation of pyruvate into the mitochondria, the pyruvate dehydrogenase complex (PDC) facilitates the conversion of pyruvate to acetyl-CoA and CO<sub>2</sub>. Each molecule of acetyl-CoA entering the TCA cycle yields 12 ATP molecules. The (PDC) has&#x000a0;3 protein subunits and requires&#x000a0;5 cofactors for its enzymatic function. The requirement of cofactors ensures the ability of the complex to be regulated. In high blood sugar levels, most acetyl-CoA is derived from glucose, specifically pyruvate. However, in starvation or fasting states, beta-oxidation contributes to acetyl-CoA production. Acetyl-CoA undergoes oxidation to CO2 in&#x000a0;8 steps, and the energy produced from these reactions is stored in NADH+H+, FADH2, and GTP. NADH+H+ and FADH2 then oxidize in the electron transport chain (mitochondrial respiratory chain), terminating in ATP synthesis.<xref ref-type="bibr" rid="article-23952.r2">[2]</xref>&#x000a0;Intermediated from the TCA cycle are precursors for both catabolic and anabolic processes. It connects several metabolic processes (eg, glycolysis, gluconeogenesis, ketogenesis, lipogenesis).<xref ref-type="bibr" rid="article-23952.r3">[3]</xref></p>
        <p>These three mechanisms regulate the activity of pyruvate dehydrogenase complex (PDC): covalent modification being the primary form of regulation, allosteric regulation, and transcriptional regulation. The covalent modification occurs when the first PDC subunit, pyruvate decarboxylase, is phosphorylated. This phosphorylation decreases PDC activity and increases ADP or pyruvate (signaling the requirement for more acetyl-CoA in the TCA cycle, which downregulates PDC). Calcium ions upregulate phosphatase&#x02019;s activity; phosphatase, in turn, dephosphorylates PDC, rendering it active. Allosteric regulation of PDC entails the direct mechanism of substrate activation or product inhibition. For instance, when acetyl-CoA from E2 or NADH from E3 is excess, these products inhibit PDC directly. In contrast, increased CoASH (precursor to acetyl-CoA) or NAD+ directly activate PDC. The last type of regulation of PDC activity is transcriptional regulation, which depends on the number of enzymes produced in fasting and fed conditions. In the fed state, enzyme production increases due to the effect of insulin, but it reduces in fasting states.<xref ref-type="bibr" rid="article-23952.r4">[4]</xref></p>
      </sec>
      <sec id="article-23952.s4" sec-type="Development">
        <title>Development</title>
        <p>The Krebs cycle is also crucial during development. For example, the energy obtained from this metabolic pathway is essential for the adequate growth of the endothelial system, which guides the formation of the blood and lymphatic vessels. If the different phases of the Krebs cycle are not present in the fetal period, the baby's heart may have problems at birth. The alteration of the cycle causes an increase in cortisol, which alters the metabolism of the placenta and fetal development, including the correct function of the future child's heart. These alterations can lead to death.</p>
      </sec>
      <sec id="article-23952.s5" sec-type="Organ Systems Involved">
        <title>Organ Systems Involved</title>
        <p>The Krebs cycle is present in every cell that uses oxygen to produce energy. This metabolic pathway is used as an anabolic cellular principle but also in the presence of catabolism.</p>
      </sec>
      <sec id="article-23952.s6" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Citrate Synthesis</bold>
</p>
        <p>The enzyme citrate synthase catalyzes the formation of citrate from acetyl CoA and oxaloacetate, often regarded as the first step of the TCA cycle. This reaction is virtually irreversible and has a delta-G-prime of -7.7 Kcal/M, strongly favoring citrate formation. The availability of substrates and products regulates the activity of citrate synthase. For instance, citrate is an inhibitor of citrate synthase, while oxaloacetate&#x02019;s binding increases its affinity for acetyl-CoA. It mentions that phosphofructokinase-1 in glycolysis is inhibited by citrate, which activates acetyl-CoA carboxylase for fatty acid synthesis. This point illustrates the interconnectivity of our metabolic cycles.<xref ref-type="bibr" rid="article-23952.r5">[5]</xref></p>
        <p>
<bold>Isomerization of Citrate</bold>
</p>
        <p>The enzyme aconitase catalyzes the reversible conversion of citrate to isocitrate, which contains an iron-sulfur center that facilitates the hydroxyl group migration. Cis-aconitate is the intermediate product of this reaction.<xref ref-type="bibr" rid="article-23952.r6">[6]</xref></p>
        <p>
<bold>Oxidative Decarboxylation of Isocitrate</bold>
</p>
        <p>The oxidative decarboxylation of isocitrate to alpha-ketoglutarate becomes catalyzed by NAD+ -dependent isocitrate dehydrogenase, producing CO2, NADH, and a proton; this is the rate-limiting step of the TCA cycle. The first reduced coenzyme production in the cycle occurs at this reaction. The tendency of this reaction to produce gas makes it irreversible. ADP and calcium ions allosterically regulate isocitrate dehydrogenase by activating it, while ATP and NADH inhibit its activity.<xref ref-type="bibr" rid="article-23952.r7">[7]</xref></p>
        <p>
<bold>Oxidative Decarboxylation of Alpha-ketoglutarate</bold>
</p>
        <p>The conversion of alpha-ketoglutarate to succinyl-CoA is catalyzed by the alpha-ketoglutarate dehydrogenase complex producing NADH, CO2, and H+. The function of the alpha-ketoglutarate dehydrogenase complex is analogous to PDC. Alpha-ketoglutarate becomes decarboxylated by E1 of this complex, transferring the 4&#x000a0;remaining carbons to thiamine pyrophosphate. Thiamine pyrophosphate is the first cofactor. Then, the succinyl group is transferred to CoASH by E2 with the help of FAD. The final step involves the resynthesis of FAD and NADH from NAD+ by E3. This last step ensures the maintenance of substrates and cofactors required to continue the dehydrogenase complex activity. The cofactors necessary for alpha-ketoglutarate dehydrogenase complex include thiamine pyrophosphate, lipoic acid, coenzyme A, NAD+, and FAD. Succinyl-CoA, NADH, and ATP inhibit the alpha-ketoglutarate dehydrogenase complex.<xref ref-type="bibr" rid="article-23952.r8">[8]</xref><xref ref-type="bibr" rid="article-23952.r9">[9]</xref></p>
        <p>
<bold>Cleavage of Succinyl Coenzyme A</bold>
</p>
        <p>The enzyme succinate thiokinase catalyzes the reversible interconversion of succinyl-CoA to succinate by cleaving succinyl CoA&#x02019;s thioester bond. The enzyme uses inorganic phosphate and dinucleotide to produce trinucleotide and CoA. This coupled reaction is called substrate-level phosphorylation, like in glycolysis.<xref ref-type="bibr" rid="article-23952.r10">[10]</xref></p>
        <p>
<bold>Oxidation of Succinate</bold>
</p>
        <p>Succinate dehydrogenase is also called complex&#x000a0;II<italic toggle="yes">&#x000a0;</italic>due to its role in the aerobic respiration chain. It catalyzes the reduction of ubiquinone to ubiquinol. The TCA cycle catalyzes the oxidation of succinate to fumarate, producing a reduced FADH2 from FAD.<xref ref-type="bibr" rid="article-23952.r11">[11]</xref></p>
        <p>
<bold>Hydration of Fumarate</bold>
</p>
        <p>Fumarate (or fumarate hydratase) catalyzes the reversible hydration to malate hydration. In another attempt to illustrate the interconnectedness of metabolic pathways, note that fumarate production also occurs in the urea cycle.<xref ref-type="bibr" rid="article-23952.r12">[12]</xref></p>
        <p>
<bold>Oxidation of Malate</bold>
</p>
        <p>Malate dehydrogenase is the catalyst in the reversible oxidation of malate to oxaloacetate, which is the last step of the TCA cycle. This enzyme plays a crucial role in NADH oxidation within the TCA cycle. The delta-G-prime is positive, which indicates that the reaction favors malate. However, consuming oxaloacetate by citrate synthase drives this reaction forward to produce more oxaloacetate.<xref ref-type="bibr" rid="article-23952.r13">[13]</xref></p>
        <p>
<bold>Cataplerotic Processes</bold>
</p>
        <p>Citric acid intermediates can leave the cycle to participate in the biosynthesis of other compounds. Citrate can be directed toward fatty acids, succinyl-CoA to heme synthesis, alpha-ketoglutarate to amino acid synthesis, purine and neurotransmitter synthesis, oxaloacetate to amino acid synthesis, and malate to gluconeogenesis.<xref ref-type="bibr" rid="article-23952.r14">[14]</xref><xref ref-type="bibr" rid="article-23952.r4">[4]</xref></p>
        <p>
<bold>Anaplerotic Processes</bold>
</p>
        <p>Intermediates are inserted into the TCA cycle to replace the cataplerotic processes and ensure the continuation of the cycle. For instance, pyruvate can enter the cycle throughout the body through pyruvate carboxylase, which inserts additional oxaloacetate into the cycle. This process causes the reaction to be pushed forward toward the already exergonic citrate synthase, as there is more oxaloacetate to participate in the reaction. The liver is another example, as it can produce alpha-ketoglutarate by oxidative deamination or transamination of glutamate.<xref ref-type="bibr" rid="article-23952.r15">[15]</xref><xref ref-type="bibr" rid="article-23952.r4">[4]</xref></p>
      </sec>
      <sec id="article-23952.s7" sec-type="Related Testing">
        <title>Related Testing</title>
        <p>Evaluating mitochondrial function involves evaluating the Krebs cycle. For example, mitochondrial malfunction is&#x000a0;1 of the diagnostic cornerstones of nonalcoholic liver disease (NAFLD). Some authors suggest comparing the plasma values of isocitrate and citrate to find mitochondrial alteration. The search for plasma values of mitochondrial metabolites can be used to understand how mitochondria work.</p>
      </sec>
      <sec id="article-23952.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Mitochondrial dysfunction can result from excess calories introduced through food; the Krebs cycle can no longer find a balance between the molecules to be degraded and the number of molecules available. Obesity shows mitochondrial alteration, with increased oxidative stress, reactive oxygen species production, inflammation, and apoptosis.</p>
        <p>Mitochondrial dysfunction can also mean overwork compared to normal values. In Duchenne pathology (in an animal model), an increase of mitochondrial metabolites is present in different tissues, such as the diaphragm, peripheral muscles, and central nervous system. The reasons are probably related to oxidative stress.</p>
      </sec>
      <sec id="article-23952.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Pyruvate Dehydrogenase Complex Deficiency</bold>
</p>
        <p>Pyruvate dehydrogenase complex deficiency is a neurodegenerative disorder due to an abnormal pyruvate decarboxylase subunit caused by a mutated X-linked PDHAD gene. This mutation leads to the impaired conversion of pyruvate to acetyl-CoA. Since there is an excess accumulation of pyruvate, lactate dehydrogenase converts into lactate, leading to potentially fatal metabolic acidosis. Other symptoms include neonatal-onset lethargy, hypotonicity, muscle spasticity, neurodegeneration, and early death.<xref ref-type="bibr" rid="article-23952.r16">[16]</xref><xref ref-type="bibr" rid="article-23952.r17">[17]</xref><xref ref-type="bibr" rid="article-23952.r18">[18]</xref></p>
        <p>
<bold>Leigh Syndrome</bold>
</p>
        <p>Subacute necrotizing encephalomyelopathy or Leigh syndrome is a progressive neurological disorder due to gene mutations encoding proteins of the PDC. In most children, the first observed sign is the inability to perform motor skills previously acquired. Other symptoms include loss of head control, poor suckling, recurrent vomiting, and loss of appetite.<xref ref-type="bibr" rid="article-23952.r19">[19]</xref><xref ref-type="bibr" rid="article-23952.r20">[20]</xref><xref ref-type="bibr" rid="article-23952.r21">[21]</xref></p>
        <p>
<bold>Thiamine Deficiency</bold>
</p>
        <p>Thiamine deficiency is similar to pyruvate dehydrogenase complex deficiency in that it shunts pyruvate to lactate, leading to metabolic acidosis. However, the culprit here is a deficiency in the active form of thiamine (thiamine pyrophosphate) rather than PDC. Acute thiamine deficiency is dry beriberi, while chronic thiamine deficiency is wet beriberi. Dry beriberi characteristically demonstrates diminished reflexes and symmetric peripheral neuropathy with motor and sensory changes. On the other hand, wet beriberi classically affects the heart, leading to tachycardia, dilated cardiomyopathy, high-output congestive heart failure, and peripheral edema.<xref ref-type="bibr" rid="article-23952.r22">[22]</xref><xref ref-type="bibr" rid="article-23952.r23">[23]</xref></p>
        <p>
<bold>Fumarase Deficiency</bold>
</p>
        <p>Fumarase deficiency is a rare autosomal recessive metabolic disorder of the TCA cycle due to a mutation in the FH gene. It is characterized by a deficiency of the enzyme fumarase hydrates, leading to fumaric acid buildup. It is a condition that mainly affects the nervous system. Affected children may have severe developmental delay, microcephaly, hypotonia, encephalopathy, seizures, psychomotor retardation, and failure to thrive.<xref ref-type="bibr" rid="article-23952.r24">[24]</xref><xref ref-type="bibr" rid="article-23952.r25">[25]</xref><xref ref-type="bibr" rid="article-23952.r26">[26]</xref><xref ref-type="bibr" rid="article-23952.r27">[27]</xref></p>
        <p>
<bold>Mutations of Isocitrate Dehydrogenase</bold>
</p>
        <p>Researchers have found isocitrate dehydrogenase mutations in several cancers, including leukemia, gliomas, and sarcomas. IDH mutations can be useful for the differential diagnosis and subclassification of human gliomas. The normal function of IDH is to catalyze the oxidative decarboxylation of isocitrate to alpha-ketoglutarate. Mutant IDH catalyzes the formation of 2-hydroxyglutarate instead of alpha-ketoglutarate. 2-hydroxyglutarate is an oncometabolite that causes DNA and histone hypermethylation, leading to neoplasia. 2-hydroxyglutarate can be used as a biomarker for cancer in patients with inborn errors of metabolism.<xref ref-type="bibr" rid="article-23952.r28">[28]</xref><xref ref-type="bibr" rid="article-23952.r29">[29]</xref><xref ref-type="bibr" rid="article-23952.r7">[7]</xref><xref ref-type="bibr" rid="article-23952.r30">[30]</xref></p>
      </sec>
      <sec id="article-23952.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23952&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23952">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23952/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23952">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-23952.s11">
        <fig id="article-23952.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Krebs Cycle Illustration&#x000a0;by K Humphreys</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="KrebsCycle-01__x1x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-23952.s12">
        <title>References</title>
        <ref id="article-23952.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cavalcanti</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Esteves-Ferreira</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Quinhones</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Pereira-Lima</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Nunes-Nesi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fernie</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Ara&#x000fa;jo</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Evolution and functional implications of the tricarboxylic acid cycle as revealed by phylogenetic analysis.</article-title>
            <source>Genome Biol Evol</source>
            <year>2014</year>
            <month>Oct</month>
            <day>01</day>
            <volume>6</volume>
            <issue>10</issue>
            <fpage>2830</fpage>
            <page-range>2830-48</page-range>
            <pub-id pub-id-type="pmid">25274566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sousa</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>D'Imprima</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vonck</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial Respiratory Chain Complexes.</article-title>
            <source>Subcell Biochem</source>
            <year>2018</year>
            <volume>87</volume>
            <fpage>167</fpage>
            <page-range>167-227</page-range>
            <pub-id pub-id-type="pmid">29464561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spydevold</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Bremer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Replenishment and depletion of citric acid cycle intermediates in skeletal muscle. Indication of pyruvate carboxylation.</article-title>
            <source>Eur J Biochem</source>
            <year>1976</year>
            <month>Dec</month>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>155</fpage>
            <page-range>155-65</page-range>
            <pub-id pub-id-type="pmid">1009946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Haddad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mohiuddin</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <chapter-title>Biochemistry, Citric Acid Cycle</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">31082116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiegand</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Remington</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Citrate synthase: structure, control, and mechanism.</article-title>
            <source>Annu Rev Biophys Biophys Chem</source>
            <year>1986</year>
            <volume>15</volume>
            <fpage>97</fpage>
            <page-range>97-117</page-range>
            <pub-id pub-id-type="pmid">3013232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pechter</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Serio</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>St&#x000fc;lke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sonenshein</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Two roles for aconitase in the regulation of tricarboxylic acid branch gene expression in Bacillus subtilis.</article-title>
            <source>J Bacteriol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>195</volume>
            <issue>7</issue>
            <fpage>1525</fpage>
            <page-range>1525-37</page-range>
            <pub-id pub-id-type="pmid">23354745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Khallaf</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight.</article-title>
            <source>Cell Biosci</source>
            <year>2017</year>
            <volume>7</volume>
            <fpage>37</fpage>
            <pub-id pub-id-type="pmid">28785398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krebs</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Metabolism of ketonic acids in animal tissues.</article-title>
            <source>Biochem J</source>
            <year>1937</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>645</fpage>
            <page-range>645-60</page-range>
            <pub-id pub-id-type="pmid">16746382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tretter</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Adam-Vizi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.</article-title>
            <source>Philos Trans R Soc Lond B Biol Sci</source>
            <year>2005</year>
            <month>Dec</month>
            <day>29</day>
            <volume>360</volume>
            <issue>1464</issue>
            <fpage>2335</fpage>
            <page-range>2335-45</page-range>
            <pub-id pub-id-type="pmid">16321804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aponte</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Chess</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Balaban</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism.</article-title>
            <source>Biochemistry</source>
            <year>2009</year>
            <month>Aug</month>
            <day>04</day>
            <volume>48</volume>
            <issue>30</issue>
            <fpage>7140</fpage>
            <page-range>7140-9</page-range>
            <pub-id pub-id-type="pmid">19527071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Winge</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Succinate dehydrogenase - Assembly, regulation and role in human disease.</article-title>
            <source>Mitochondrion</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>393</fpage>
            <page-range>393-401</page-range>
            <pub-id pub-id-type="pmid">20226277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yogev</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Yogev</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shaulian</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Pines</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response.</article-title>
            <source>PLoS Biol</source>
            <year>2010</year>
            <month>Mar</month>
            <day>09</day>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>e1000328</fpage>
            <pub-id pub-id-type="pmid">20231875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min&#x000e1;rik</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tom&#x000e1;skov&#x000e1;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koll&#x000e1;rov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Antal&#x000ed;k</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Malate dehydrogenases--structure and function.</article-title>
            <source>Gen Physiol Biophys</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>257</fpage>
            <page-range>257-65</page-range>
            <pub-id pub-id-type="pmid">12537350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hertz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hertz</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cataplerotic TCA cycle flux determined as glutamate-sustained oxygen consumption in primary cultures of astrocytes.</article-title>
            <source>Neurochem Int</source>
            <year>2003</year>
            <season>Sep-Oct</season>
            <volume>43</volume>
            <issue>4-5</issue>
            <fpage>355</fpage>
            <page-range>355-61</page-range>
            <pub-id pub-id-type="pmid">12742079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibala</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>MacLean</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Saltin</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Anaplerotic processes in human skeletal muscle during brief dynamic exercise.</article-title>
            <source>J Physiol</source>
            <year>1997</year>
            <month>Aug</month>
            <day>01</day>
            <volume>502 ( Pt 3)</volume>
            <issue>Pt 3</issue>
            <fpage>703</fpage>
            <page-range>703-13</page-range>
            <pub-id pub-id-type="pmid">9279819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rutledge</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pyruvate Dehydrogenase Complex Deficiency: An Unusual Cause of Recurrent Lactic Acidosis in a Paediatric Critical Care Unit.</article-title>
            <source>J Crit Care Med (Targu Mures)</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-75</page-range>
            <pub-id pub-id-type="pmid">31161145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Subramony</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Shuster</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stacpoole</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.</article-title>
            <source>Mol Genet Metab</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>106</volume>
            <issue>3</issue>
            <fpage>385</fpage>
            <page-range>385-94</page-range>
            <pub-id pub-id-type="pmid">22896851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Otero</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>LeGris</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Pyruvate dehydrogenase deficiency.</article-title>
            <source>J Med Genet</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>875</fpage>
            <page-range>875-9</page-range>
            <pub-id pub-id-type="pmid">7853374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Rahman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thorburn</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Nuclear Gene-Encoded Leigh Syndrome Spectrum Overview</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bean</surname>
                <given-names>LJH</given-names>
              </name>
              <name>
                <surname>Gripp</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2015</year>
            <month>10</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">26425749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ball</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thorburn</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Mitochondrial DNA-Associated Leigh Syndrome Spectrum</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bean</surname>
                <given-names>LJH</given-names>
              </name>
              <name>
                <surname>Gripp</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2003</year>
            <month>10</month>
            <day>30</day>
            <pub-id pub-id-type="pmid">20301352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruhoy</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Saneto</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>The genetics of Leigh syndrome and its implications for clinical practice and risk management.</article-title>
            <source>Appl Clin Genet</source>
            <year>2014</year>
            <volume>7</volume>
            <fpage>221</fpage>
            <page-range>221-34</page-range>
            <pub-id pub-id-type="pmid">25419155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tarasenko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Napoli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Giulivi</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Neurological, Psychiatric, and Biochemical Aspects of Thiamine Deficiency in Children and Adults.</article-title>
            <source>Front Psychiatry</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>207</fpage>
            <pub-id pub-id-type="pmid">31019473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r23">
          <label>23</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Wiley</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Vitamin B1 (Thiamine) Deficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30725889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Balasubramaniam</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Fumarase Deficiency: A Safe and Potentially Disease Modifying Effect of High Fat/Low Carbohydrate Diet.</article-title>
            <source>JIMD Rep</source>
            <year>2018</year>
            <volume>40</volume>
            <fpage>77</fpage>
            <page-range>77-83</page-range>
            <pub-id pub-id-type="pmid">29052812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r25">
          <label>25</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Coman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kranc</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Fumarate Hydratase Deficiency</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bean</surname>
                <given-names>LJH</given-names>
              </name>
              <name>
                <surname>Gripp</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2006</year>
            <month>7</month>
            <day>5</day>
            <pub-id pub-id-type="pmid">20301679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gellera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Uziel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rimoldi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeviani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laverda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carrara</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>DiDonato</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes.</article-title>
            <source>Neurology</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3 Pt 1</issue>
            <fpage>495</fpage>
            <page-range>495-9</page-range>
            <pub-id pub-id-type="pmid">2314594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ezgu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Krejci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wilcox</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene.</article-title>
            <source>Gene</source>
            <year>2013</year>
            <month>Jul</month>
            <day>25</day>
            <volume>524</volume>
            <issue>2</issue>
            <fpage>403</fpage>
            <page-range>403-6</page-range>
            <pub-id pub-id-type="pmid">23612258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kogiso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XN</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer.</article-title>
            <source>Med Chem</source>
            <year>2018</year>
            <volume>14</volume>
            <issue>7</issue>
            <fpage>715</fpage>
            <page-range>715-724</page-range>
            <pub-id pub-id-type="pmid">29792149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reitman</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>2010</year>
            <month>Jul</month>
            <day>07</day>
            <volume>102</volume>
            <issue>13</issue>
            <fpage>932</fpage>
            <page-range>932-41</page-range>
            <pub-id pub-id-type="pmid">20513808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23952.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pirozzi</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>648</fpage>
            <page-range>648-52</page-range>
            <pub-id pub-id-type="pmid">22002076</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
